Please login to the form below

Not currently logged in
Email:
Password:

New president and CSO for Takeda San Diego

Dr Keith Wilson is named the new president and CSO of Takeda San Diego

Dr Keith Wilson has been named president and CSO of Takeda San Diego.

Wilson will be responsible for overseeing all activities related to Takeda San Diego, Japan-headquartered Takeda's US-based drug discovery company.

Before the promotion, Wilson served dual roles as vice-president of structural biology and vice-president of business development at Takeda. Prior to Takeda, Wilson spent 10 years with Vertex Pharmaceuticals, co-leading drug discovery programmes and significant alliance projects.

Wilson is a contributing author on more than 30 peer-reviewed publications and co-inventor of six issued US patents covering multiple drug candidates.

4th September 2007

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Fishawack Group of Companies

The Fishawack Group of Companies is one of the largest independent medical communications and medical marketing specialists, with teams in...

Latest intelligence

New from the PhRMA: Diversity in clinical trials principles summarised
In November 2020, PhRMA announced the first-ever, industry-wide principles on clinical trial diversity. The principles were approved by the PhRMA Boards of Directors and will take effect in April 2021....
New from the FDA: Diversity in clinical trials guidance summarised
In November 2020, the FDA released guidance to enable greater diversity in clinical trials through changes to eligibility criteria, enrolment practices, and trial designs....
5 steps to effective clinical trial branding
When recruiting patients for your clinical trial, you want the materials and information around it to be seen as reputable and professional. To make it clear what the clinical trial...

Infographics